Back to MetLife Investment Management, LLC MetLife Investment Management, LLC

SMMTSMMT

Showing 8 of 13 quarters

Position history for MetLife Investment Management, LLCMetLife Investment Management, LLC's holdings in Summit Therapeutics Inc.

Yes. MetLife Investment Management holds 7,508 shares of SMMT (Summit Therapeutics), worth $109,392, as of its Q2 2026 13F filing. It increased the position by 322 shares (+4.5%) from Q1 2026. MetLife Investment Management has held SMMT since Q2 2023, across 13 quarterly 13F filings.

Current Value

$109,392

Current Shares

7,508

Total Value Change

-$1M

Total Shares Change

-43,917

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
7,508
+4.5%
$109,3920.0%$14.57
23
2026-Q1
Decreased
7,186
-4.8%
$136,2470.0%$18.96
0
2025-Q4
Increased
7,544
+0.9%
$131,9450.0%$17.49
22
2025-Q3
Increased
7,478
+3.0%
$154,4950.0%$20.66
23
2025-Q2
Decreased
7,263
-86.7%
$154,5570.0%$21.28
0
2025-Q1
Decreased
54,691
-1.3%
$1.1M0.0%$19.29
0
2024-Q4
Increased
55,406
+7.7%
$988,7200.0%$17.85
27
2024-Q3
Unchanged
51,425
0.0%
$1.1M0.0%$20.89
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used